Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹27.00 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹27.00 Cr |
| Fresh Issue | ₹25.64 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹68.00-72.00 per share |
| Discount | Retail: 0.00,Employee: 0.00,ShareHolder: 0.00 |
| NSE Code | AAKAAR |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,600 shares and in multiples thereof
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.
The company deals in speciality products for Dermatologists, Plastic Surgeons, Aesthetic Physicians, Cosmetologists.
The company's product portfolio encompasses both own brands, which consist of domestically manufactured products and internationally produced devices, and imported brands sourced from countries such as South Korea, Spain, Italy, and Austria.
The company supplies products and devices mainly to dermatologists, plastic surgeons, and aesthetic physicians, who sell them to end consumers and use some consumables in treatments.
The company's product range includes the following:-
The company has branches across India with a team of 90 trained sales and service engineers, serving thousands of satisfied customers.
The company sells its products to the states of Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.
Competitive Strength
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding working capital requirements of the Company | 20.35 |
| 2 | General Corporate Purposes | 3.29 |
| 3 | Issue Expenses | 3.36 |
| Total | 27.00 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 51.85 | 34.01 | 23.23 |
| Total Income | 61.76 | 46.27 | 32.88 |
| Profit After Tax | 6.04 | 2.87 | 2.15 |
| EBITDA | 9.74 | 5.00 | 3.53 |
| NET Worth | 23.20 | 12.53 | 9.66 |
| Reserves and Surplus | 12.78 | 11.84 | 8.96 |
| Total Borrowing | 22.74 | 15.06 | 5.87 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2025 |
|---|---|
| ROCE | 21.02% |
| Debt / Equity | 0.98% |
| RoNW | 33.81% |
| PAT Margin | 9.81% |
| EBITDA Margin | 15.81% |
| Price to Book Value | 5.23 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 5.79 | 4.26 |
| P/E (x) | 12.43 | 16.9 |
| Promoter Holding | 91.11% | 67.01% |
| Market Cap | ₹102.04 Cr. | |
